Yoram Reiter

USPTO Granted Patents = 20 (Patent Applications = 16)

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 11 (Patent Applications = 16)

Average Co-Inventor Count = 2.3

ph-index = 6

Forward Citations = 83(Granted Patents)

Company Filing History:

17 out of 944

Technion Research & Development Foundation Limited

patents

2 out of 505

Teva Pharmaceutical Industries Limited

patents

1 out of 126

Tel Hashomer Medical Research Infrastructure and Services Ltd.

patents

4. 1 out of 4

Adicet Therapeutics, Inc.

patents

5. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12252547 - Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of same (2025-03-18),

2. 11485785 - Antibodies capable of binding HLA-A2/TyrD in an HLA restricted manner and uses thereof (2022-11-01),

3. 11001642 - Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of same (2021-05-11),

4. 9695410 - Isolated high affinity entities with T-cell receptor like specificity towards native complexes of MHC class II and glutamic acid decarboxylase (GAD) autoantigenic peptides (2017-07-04),

5. 9616112 - Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof (2017-04-11),

6. 9095533 - Antigen-presenting complex-binding compositions and uses thereof (2015-08-04),

7. 9023348 - Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof (2015-05-05),

8. 8747855 - Anti human immunodeficiency antibodies and uses thereof (2014-06-10),

9. 8541185 - Method of predicting responsiveness to autologous adoptive cell transfer therapy (2013-09-24),

10. 8449889 - Immuno-molecules containing viral proteins, compositions thereof and methods of using (2013-05-28),

11. 8361473 - Antibodies and their uses for diagnosis and treatment of cytomegalovirus infection and associated diseases (2013-01-29),

12. 8354066 - Artificial receptors (2013-01-15),

13. 8022190 - Immuno-molecules containing viral proteins, compositions thereof and methods of using (2011-09-20),

14. 7977457 - Fusion proteins, uses thereof and processes for producing same (2011-07-12),

15. 7718777 - MHC-peptide complex binding ligands (2010-05-18),

Title: Yoram Reiter: Pioneering Inventor from Haifa, Israel

Introduction: Yoram Reiter is a distinguished inventor hailing from the vibrant city of Haifa, Israel. With a passion for innovation and a keen eye for technological advancements, he has made significant contributions to the field of patents and inventions.

Latest Patents: Yoram Reiter's latest patents showcase his expertise in cutting-edge technologies, including advancements in renewable energy, artificial intelligence, and medical devices. His innovative solutions have garnered attention worldwide for their potential to revolutionize various industries.

Career Highlights: Throughout his illustrious career, Yoram Reiter has been recognized for his groundbreaking inventions that have pushed the boundaries of what is possible. His commitment to excellence and relentless pursuit of innovation have earned him a reputation as a trailblazer in the field of patents.

Collaborations: Yoram Reiter has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has led to the successful development and commercialization of several groundbreaking technologies.

Conclusion: Yoram Reiter's passion for innovation, coupled with his exceptional talent for inventing, has solidified his position as a prominent figure in the world of patents. His contributions continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.